
Photo from David Lee/X
Aug 12, 2024, 22:09
David Lee: Best part of ASCO breakthrough 2024
David Lee shared on X:
“Best part of ASCO breakthrough 2024 – meet old friends and make new ones. Love this bunch of smart, genuine and fun people. A great platform to unite us.”
Source: David Lee/X
Dr. David Lee Dai Wee is a Consultant Clinical Oncologist at the University of Malaya Medical Centre and a lecturer at the Faculty of Medicine, University of Malaya.
He is the principal investigator for multiple international multicenter clinical trials, specializing in early-phase studies, thoracic cancers, and head and neck cancers.
Dr. Lee received the ASCO Leadership Development Program – Asia Pacific award in 2021-2022 and the ASCO International Development and Education Award (IDEA) in 2024, as well as the IASLC Academy Award in 2024.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 10:07
Feb 21, 2025, 09:58
Feb 21, 2025, 09:54
Feb 21, 2025, 09:45
Feb 21, 2025, 09:35
Feb 21, 2025, 09:18
Feb 21, 2025, 09:07